Western blot analysis further confirmed these findings, demonstrating that fisetin (40 μM) treatment elevated the expression of PKCα by approximately 3-fold in both melanoma cells and α-MSH-stimulated melanoma cells. The gene discussed is PRKCA; the disease is melanoma.